Structural and Mechanistic Insights into Atypical Bacterial Topoisomerase Inhibitors
Novel bacterial topoisomerase inhibitors (NBTIs) targeting DNA gyrase and topoisomerase IV constitute a new antibacterial class for deadly pathogens such as MRSA. While most NBTIs induce gyrase-mediated single-strand DNA breaks, a subset of amide NBTIs induces both single-strand and double-strand DNA breaks. Here, we report the X-ray crystal structures of two such amide NBTIs, <b>148</b> and <b>185</b>, and demonstrate an unusual binding mode characterized by engagement of both GyrA D83 and R122. The synthesis of two isosteric triazole NBTIs is also described, one of which (<b>342</b>) affords only single-strand DNA breaks, while the other (<b>276</b>) also induces both single- and double-strand DNA breaks. A combination of docking and molecular dynamics simulations is employed to further investigate the potential structural underpinnings of differences in DNA cleavage.
Authors
- Mark J. Mitton‐Fry (ORCID: https://orcid.org/0000-0002-6715-8836)
- Steffen Lindert (ORCID: https://orcid.org/0000-0002-3976-3473)
- Craig A. McElroy (ORCID: https://orcid.org/0000-0001-5950-0120)
- Charles E. Bell (ORCID: https://orcid.org/0000-0001-6486-9408)
- Steven C. Ratigan
- Jack C. Yalowich (ORCID: https://orcid.org/0000-0001-5414-573X)
- Paul Toth (ORCID: https://orcid.org/0009-0003-3814-7657)
- Joshua W. Powell (ORCID: https://orcid.org/0000-0001-8912-471X)
- Sydney R Cassel
Institutions
- American Association of Colleges of Pharmacy (US)
Publication Details
- Journal
- ACS Medicinal Chemistry Letters
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1021/acsmedchemlett.5c00060
- Primary Topic
- Cancer therapeutics and mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Dr. Ralph and Marian Falk Medical Research Trust
- National Institute of Allergy and Infectious Diseases